Larson Financial Group’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $141 | Hold |
|
|||||
|
2023
Q2 | $117 | Sell |
|
|||||
|
2023
Q1 | $134 | Hold |
|
|||||
|
2022
Q4 | $1.19K | Hold |
|
|||||
|
2022
Q3 | $2K | Hold |
|
|||||
|
2022
Q2 | $2K | Hold |
|
|||||
|
2022
Q1 | $3K | Sell |
|
|||||
|
2021
Q4 | $36K | Sell |
|
|||||
|
2021
Q3 | $209K | Sell |
|
|||||
|
2021
Q2 | $431K | Buy |
|
|||||
|
2021
Q1 | $334K | Buy |
|
|||||
|
2020
Q4 | $343K | Buy |
|
|||||
|
2020
Q3 | $118K | Buy |
|
|||||
|
2020
Q2 | $98K | Hold |
|
|||||
|
2020
Q1 | $75K | Buy |
|
|||||
|
2019
Q4 | $30K | Hold |
|
|||||
|
2019
Q3 | $44K | Hold |
|
|||||
|
2019
Q2 | $65K | Hold |
|
|||||
|
2019
Q1 | $58K | Buy |
|
|||||
|
2018
Q4 | $73K | Buy |
|